Bixiye
QP63-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Empaveli (pegcetacoplan)
Taariikhda barnaamijka Dhaqangalayso Agosto 11, 2021
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2111 - 2120 ee natiijooyinka 3167
Bixiye
QP65-21 Minnesota Health Care Programs Providers use of the Interactive Care Reviewer
Taariikhda barnaamijka Dhaqangalayso Agosto 11, 2021
Bixiye
QP64-21 Patient360 Enhancement for Minnesota Health Care Programs Members
Taariikhda barnaamijka Dhaqangalayso Agosto 11, 2021
Bixiye
P46-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Sleep Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda barnaamijka Dhaqangalayso Agosto 02, 2021
Bixiye
P45-21 Behavioral Health Coding for Early Intensive Behavioral Intervention and Applied Behavioral Analysis
Taariikhda barnaamijka Dhaqangalayso Agosto 02, 2021
Bixiye
P44-21 Urine Drug Testing Reimbursement Policy
Taariikhda barnaamijka Dhaqangalayso Agosto 02, 2021
Bixiye
P48-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda barnaamijka Dhaqangalayso Agosto 02, 2021
Bixiye
P47-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective October 4, 2021
Taariikhda barnaamijka Dhaqangalayso Agosto 02, 2021
Bixiye
2021 August Bulletins
Taariikhda barnaamijka Dhaqangalayso Agosto 02, 2021
Bixiye
QP61-21 Final Determination Letter to be Sent from Cotiviti
Taariikhda dhaqangalka Barnaamijka: Jul 28, 2021